Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Greenstar Biosciences Corp. (C:GSTR)

Business Focus: Alternative Medicine

Jun 17, 2020 01:53 pm ET
GreenStar Biosciences: Jonathan Gilbert, Eleusian Biosciences CEO, to Speak at Peak Asset Management's Psychedelic Investment Webinar
Eleusian Biosciences CEO, Jonathan Gilbert, will speak at the Peak Asset Management's Webinar on Thursday June 18th at 7:30PST. GreenStar recently announced non-binding LOI with Eleusian
Jun 16, 2020 09:46 am ET
IIROC Trade Resumption - GSTR
VANCOUVER, BC, June 16, 2020 /CNW/ - Trading resumes in:
Jun 16, 2020 09:27 am ET
Greenstar Biosciences Signs Agreement to Acquire 100% of Eleusian Biosciences Corp.
Strategic acquisition by GreenStar to add innovative company focused on the development of effective therapeutics using psychedelic medicine
Jun 12, 2020 03:12 pm ET
IIROC Trading Halt - GSTR
VANCOUVER, BC, June 12, 2020 /CNW/ - The following issues have been halted by IIROC:
May 25, 2020 06:30 am ET
GreenStar Biosciences Announces Stock Option Issuance and Cancellation of Stock Options
Vancouver, British Columbia--(Newsfile Corp. - May 25, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) ("GreenStar" or the "Company"), announces it has granted stock options to acquire a total of 200,000 common shares of the Company to a director of the Company. The options are exercisable at a price of $0.14 per share and expire three years from the date of grant. The options are subject to various vesting provisions where 150,000 of the options granted vest immediately on the grant date, 7,143 options vest monthly from June 30, 2020 to November 30, 2020 and 7,142 options vest on December 31, 2020.
Apr 17, 2020 05:00 pm ET
GreenStar Biosciences Announces Resignation of Independent Board Member
Vancouver, British Columbia--(Newsfile Corp. - April 17, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) ("GreenStar" or the "Company"), announced today the resignation of Faizaan Lalani from its Board of Directors for personal reasons.
Mar 02, 2020 08:00 am ET
GreenStar Biosciences' Cowlitz Reports Record Breaking Revenues of US$19.5 M for 2019
Vancouver, British Columbia--(Newsfile Corp. - March 2, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) ("GreenStar" or the "Company"), is pleased to announce that its tenant partner Cowlitz County Cannabis Cultivation Inc. ("Cowlitz") has generated over US$19.5 million in gross sales revenues for 2019.
Feb 24, 2020 07:24 pm ET
GreenStar Biosciences Announces New CEO and Board Changes
Vancouver, British Columbia--(Newsfile Corp. - February 24, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company"), is pleased to announce the appointment of Mr. Thomas Baird as Chief Executive Officer and director of the Company. Mr. Baird's appointment is a key step in furthering GreenStar's next phase of expansion. Mr. Baird replaces Mr. Rahim Rajwani who resigned as CEO and director but will continue providing strategic direction to the Company with his new appointment as Chairman of the Company's Strategic Advisory Board, concentrating on executing its pipeline of M&A initiatives and strategic partnerships.
Feb 07, 2020 08:00 pm ET
GreenStar Biosciences Announces Grants and Cancellation of Stock Options
Vancouver, British Columbia--(Newsfile Corp. - February 7, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company"), announces it has granted stock options to acquire a total of 3,378,836 common shares of the Company to certain officers and consultants of the Company. The options are exercisable at a price of $0.085 per share and expire five years from the date of grant. The options are subject to various vesting provisions where 2,378,836 of the options granted vest immediately on the grant date, and 1,000,000 options vest as to 50% immediately and 50% vest on the first anniversary of the grant date. The Company also announces the cancellation of a total of 3,050,000 previously granted stock options made to certain directors, officers and consultants.
Jan 17, 2020 07:00 pm ET
Greenstar Biosciences Announces Grant of Stock Options
Vancouver, British Columbia--(Newsfile Corp. - January 17, 2020) -  GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company"), announces it has granted stock options to acquire a total of 1,900,000 common shares of the Company to certain officers, directors and consultants of the Company. The options are exercisable at a price of $0.14 per share and expire five years from the date of grant. The options are subject to various vesting provisions where 1,650,000 of the options granted vest immediately on the grant date, and 250,000 options vest as to 50% immediately and 50% vest on the first anniversary of the grant date.
Dec 20, 2019 05:00 pm ET
Greenstar Biosciences Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - December 20, 2019) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company"), announces that it attended the recent MJBizCon cannabis investment conference to held in Las Vegas, Nevada. MJBizCon is the premier cannabis investment conference with over 35,000 attendees from 70+ countries, including over 1,250 investors and more than 1,300 exhibitors in attendance, making MJBizCon the largest gathering of cannabis business professional in the world.
Dec 10, 2019 03:08 pm ET
GreenStar Biosciences Comments on Market Activity
Vancouver, British Columbia--(Newsfile Corp. - December 10, 2019) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company"), at the request of the Investment Industry Regulatory Organization of Canada (IIROC), has issued this press release to confirm that the Company's management is not aware of any material undisclosed development with respect to the Company that would account for the recent increase in market activity.
Dec 10, 2019 02:22 pm ET
IIROC Trade Resumption - GSTR
VANCOUVER, Dec. 10, 2019 /CNW/ - Trading resumes in:
Dec 10, 2019 01:24 pm ET
IIROC Trading Halt - GSTR
VANCOUVER, Dec. 10, 2019 /CNW/ - The following issues have been halted by IIROC:
Dec 06, 2019 10:30 pm ET
Greenstar Biosciences Announces M&A Focussed Strategic Additions to Its Executive Team and Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - December 6, 2019) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company"), announces that it has engaged Invictus Accounting Group LLP ("Invictus") to provide CFO and strategic advisory services to the Company.
Dec 02, 2019 07:30 am ET
GreenStar Biosciences Announces Transformational Phase One Expansion at Cowlitz
Vancouver, British Columbia--(Newsfile Corp. - December 2, 2019) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company"), is pleased to announce that its tenant partner Cowlitz County Cannabis Cultivation Inc. ("Cowlitz") has completed the first phase of its expansion initiatives with the completion of several grow rooms at its existing facilities. This allows Cowlitz to produce its own high quality cannabis to meet its growing customer demands.
Nov 21, 2019 07:00 am ET
GreenStar Biosciences Announces Achievement of DTC Eligibility
Vancouver, British Columbia--(Newsfile Corp. - November 21, 2019) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC PINK: GTSIF)  ("GreenStar" or the "Company"), a growth-oriented technology and services company that provides real estate, financial, management and other support to licensed cannabis businesses in the United States, is pleased to announce the Company has secured DTC eligibility by The Depository Trust Company ("DTC") for electronic settlement and transfer of its common shares in the United States.
Nov 20, 2019 07:30 am ET
Strength in Numbers: The Name You Don't Know in Cannabis, But Should ... GreenStar Biosciences -- CFN Media
Seattle, Washington--(Newsfile Corp. - November 20, 2019) - CFN Media (OTCQB: CNFN), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF). The company is making its mark in the cannabis industry and doing so through partnerships that don't put its name in lights, but they certainly put value in the company. The tech and services company is a provider of real estate, financial, management, IP and branding support to licensed U.S. cannabis businesses. In these efforts, GreenStar partners and makes investments in innovative or disruptive technologies and businesses.
Oct 10, 2019 07:00 am ET
Greenstar Biosciences Achieves OTC Listing
Vancouver, British Columbia--(Newsfile Corp. - October 10, 2019) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company") is pleased to announce the Company has been approved for trading its common shares on the OTC Pink market, a US trading platform that is operated by the OTC Markets Group in New York. The Company will be quoted on the OTC under symbol "GTSIF" and the Company's common shares will continue to trade on the Canadian Securities Exchange under the symbol "GSTR".
Oct 08, 2019 07:00 am ET
Priming for Expansion, GreenStar Strikes a Deal with Progressive Herbs -- CFN Media
Seattle, Washington--(Newsfile Corp. - October 8, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing GreenStar Biosciences Corp. (CSE: GSTR). GreenStar already had a strong cannabis market presence through its stake in Cowlitz County Cannabis Cultivation, a leading player in Washington State. Primed for expansion, the company has struck a deal with Progressive Herbs Inc., forging a new joint venture that should make all involved even stronger.
Oct 03, 2019 07:00 am ET
GreenStar Biosciences Shares An Open Letter to Shareholders from the CEO Highlighting Recent Successes and Future Plans
Vancouver, British Columbia--(Newsfile Corp. - October 3, 2019) - GreenStar Biosciences Corp. (CSE: GSTR) ("GreenStar" or the "Company") is pleased to share an open letter to shareholders written by Rahim Rajwani, GreenStar's CEO and Director.
Oct 01, 2019 10:42 am ET
GreenStar Biosciences' Cowlitz Generates US$11.8M in First Seven Months of 2019
Vancouver, British Columbia--(Newsfile Corp. - October 1, 2019) - GreenStar Biosciences Corp. (CSE: GSTR) ("GreenStar" or the "Company"), is pleased to announce that its tenant partner Cowlitz County Cannabis Cultivation Inc. ("Cowlitz") has generated more than US$11.87 million in gross sales revenues during the first seven months to July 31, 2019.
Sep 11, 2019 08:00 am ET
A Leader In Washington, GreenStar Eyes Expansion -- CFN Media
Seattle, Washington--(Newsfile Corp. - September 11, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing GreenStar Biosciences Corp. (CSE: GSTR).
Sep 11, 2019 07:00 am ET
Greenstar Biosciences Announces Successful Testing Results Using Proprietary Grow Technology
Vancouver, British Columbia--(Newsfile Corp. - September 11, 2019) - GreenStar Biosciences Corp. (CSE: GSTR) ("GreenStar" or the "Company"), a growth-oriented technology and services company that provides real estate, financial, management and other support to licensed cannabis businesses in the United States, is pleased to announce that it has received positive results from an initial cultivation test involving the growth of approximately 2,500 plants using the proprietary patent-pending grow and cultivation technology of Progressive Herbs Inc. ("Progressive"). As previously announced, Capri PHGS LLC ("Capri"), a 50/50 joint venture between the Company and Progressive, holds the exclusive license to utilize Progressive's proprietary cultivation technology. The Company also received results from independent laboratory testing on the three strains used in the initial cultivation test, which demonstrated total cannabinoid percentages between 22.85% to 32.54%, depending on the strain tested.
Sep 03, 2019 07:00 am ET
GreenStar Biosciences Provides Corporate Update on Operations
Vancouver, British Columbia--(Newsfile Corp. - September 3, 2019) - GreenStar Biosciences Corp. (CSE: GSTR) ("GreenStar" or the "Company"), a growth-oriented technology and services company that provides real estate, financial, management and other support to licensed cannabis businesses in the United States, is pleased to provide the following update to inform shareholders about its current operations.
Aug 08, 2019 08:04 pm ET
GreenStar Biosciences Retains Integral Wealth Securities Ltd. for Market Making
Vancouver, British Columbia--(Newsfile Corp. - August 8, 2019) - GreenStar Biosciences Corp. (CSE: GSTR) ("GreenStar" or the "Company"), a growth-oriented technology and services company that provides real estate, financial, management and other support to licensed cannabis businesses in the United States, is pleased to announce that it has retained Integral Wealth Securities Ltd. ("Integral") to provide Market-Making services in accordance with Canadian Securities Exchange ("CSE") policies.
Jul 25, 2019 08:30 am ET
GreenStar Biosciences Announces Changes to Board and Management Team and Formation of Strategic Advisory Board
VANCOUVER, July 25, 2019 /CNW/ - GreenStar Biosciences Corp. ("GreenStar" or the "Company") (CSE:GSTR), a growth-oriented technology and services company that provides real estate, financial, management and other support to licensed cannabis businesses in the United States, is pleased to provide the following update with respect to changes to its senior management team and board of directors (the "Board"). In addition, the Company is pleased to announce the formation and launch of its strategic advisory board (the "Advisory Board").
Jun 19, 2019 08:30 am ET
GreenStar Biosciences Announces Senior Management Addition
VANCOUVER, BC / ACCESSWIRE / June 19, 2019 / GreenStar Biosciences Corp. ("GreenStar" or the "Company") (CSE: GSTR) is pleased to announce that, effective today, Mr. Rahim Rajwani has been appointed as Chief Executive Officer of the Company. Mr. Ralph Olson, the Company's current CEO, will be moving to the role of President of GreenStar. Subject to final board approval, Mr. Rajwani will also join the board of directors of the Company. Leighton Bocking will transition from his current role of President and continue to work w
Jun 18, 2019 09:00 am ET
GreenStar Biosciences Provides Corporate Update
VANCOUVER, BC / ACCESSWIRE / June 18, 2019 / GreenStar Biosciences Corp. ("GreenStar" or the "Company") (CSE: GSTR) is pleased to provide the following corporate update with respect to the business and prospects of GreenStar Biosciences Corp.
Jun 12, 2019 08:00 am ET
Greenstar Announces Execution of Long Term Cannabis Flower Supply Agreement
VANCOUVER, BC / ACCESSWIRE / June 12, 2019 / Greenstar Biosciences Corp. ("Greenstar" or the "Company") (CSE: GSTR) is pleased to announce that its tenant partner in Washington State, Cowlitz County Cannabis Cultivation, Inc. ("Cowlitz"), has signed a long-term supply agreement with Pat Dullanty, owner and operator of an 18 acre tier 3 outdoor grow facility located at 26425 S Rupp Rd, Cheney, Washington 99001. Pursuant to this new agreement, Cowlitz will have access to up to 25,000 pounds, dry wei
Jun 10, 2019 09:00 am ET
CSE New Listing - GreenStar Biosciences Commences Trading on the Canadian Securities Exchange - Video News Alert on Investmentpitch.com
Vancouver, British Columbia--(Newsfile Corp. - June 10, 2019) - GreenStar Biosciences (CSE: GSTR) is one of the latest new listing on the Canadian Securities Exchange, having previously traded on the TSX Venture Exchange as Bethpage Capital, prior to a change of business. GreenStar is the owner of the property leases, brands and intellectual property of Cowlitz County Cannabis Cultivation Inc.